Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to adapt and test a cognitive behavioral therapy (CBT) treatment that can be administered concurrently with the Veteran's Health Administration (VHA) MOVE! weight management program for Veterans with DSM-5 Binge Eating Disorder (BED) and high weight.
To date, there have been limited studies of Binge Eating Disorder (BED) and high weight utilizing combined eating disorder and weight management approaches in real-world settings, nor studies with complex and diverse samples. The objective of this project was to conduct a clinical trial that would produce evidence-based findings for a diverse patient group in a healthcare setting. Specifically, we aimed to address comorbid BED and high weight among Veterans in the Veteran's Health Administration (VHA), the largest integrated healthcare system in the U.S., by testing the effectiveness of VA's evidence-based weight management program, called MOVE!, versus MOVE! administered concurrent with a brief, clinician-led cognitive-behavioral therapy (CBT).
Aim 1: To assess the effectiveness of MOVE! (treatment-as-usual) to MOVE! plus brief, clinician-led CBT (MOVE!+CBT).
Hypothesis 1: It is hypothesized that MOVE!+CBT will have greater improvements on the primary outcomes of eating pathology and binge eating (reductions in binge frequency and percentage of participants who are binge remitted) than MOVE! alone.
Hypothesis 2: It is further hypothesized that MOVE!+CBT will have greater improvements on secondary measures of mental health, quality of life, and other eating behaviors.
Aim 2: To conduct exploratory analyses assessing the effectiveness of MOVE! to MOVE! vs. MOVE!+CBT on weight outcomes.
Hypothesis: It is hypothesized that MOVE!+CBT will have greater weight loss, and a larger percentage who achieve 5% weight loss, than MOVE! alone.
Note that several planned outcomes were not able to be analyzed for this project. Due to pandemic/COVID-19 related impacts, lipid profile data from in-person blood draws were inconsistently collected. Likewise, MOVE! adherence could not be measured with in-person session attendance as delivery for this intervention was expanded to include technology-delivered modalities. To fill these gaps, an "Impact of COVID-19" measure was added soon after the onset of the pandemic, but these questionnaire items did not hold up over the course of time and were removed. Finally, the 24-Hour Food Frequency Questionnaire (24 Hour-FFQ), a brief screening tool of food intake, was a measure specially designed for this study. Validation and publication of this screener was successful (The 24-hour food frequency assessment screening tool (FAST24): Development and evaluation of a novel dietary screener to identify foods associated with weight change - PubMed (nih.gov)), however, the lack of granular dietary data did not lend itself to measuring outcome. None of the measures removed represented primary or secondary outcomes for this project.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MOVE! | Active Comparator | Weight management delivered as Treatment-as-Usual |
|
| MOVE!+CBT | Experimental | Weight management delivered as Treatment-as-Usual plus use of a short duration, low-intensity CBT for recurrent binge eating. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MOVE! | Behavioral | Participants randomized to the MOVE!(or TeleMOVE!) arm only. MOVE! is 16 weeks of 60-minute weekly groups that are led by a physical therapist, dietician, and/or clinical health psychologist. Clinicians utilize materials available online and encourage the use, but do not require or provide food diaries. TeleMOVE! is a 90-day program utilizing technology to provide home-based messaging focusing on health education and as needed clinician contact. *TeleMOVE! was added as an option since many in-person MOVE! programs were on pause due to the pandemic. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Eating Disorder Examination-Self-report Questionnaire (EDE-Q) | The EDE-Q is the self-report version of the more intensive EDE interview. Research has documented that the EDE-Q performs well as a measure of change in treatment trials and has adequate convergence with the interview format. The EDE-Q generates the same frequency data for eating behaviors (binge eating and overeating) in the past 28 days, and the same four subscales reflecting eating disorder pathology. Score on a scale 0-6; higher=worse | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Change in Binge Episodes From Eating Disorder Examination Interview | The EDE is a clinician administered interview that is considered to be the gold standard for diagnosing eating disorders and assessing binge frequency. Number of binges; higher=worse | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Patient Health Questionnaire-9 (PHQ-9) | The PHQ-9 is a 9-item version, is a self-report measure for the symptoms of depression. Score on scale from 0-27; higher=worse | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Change in PTSD Checklist (PCL-5) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in BMI | BMI will be calculated based upon self-reported height and weight. A BMI of 25.0-29.9 indicates overweight, and 30.0 above indicates obesity. Kg/m 2; higher=worse | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Change in Weight Control Strategies Scale (WCSS) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robin M Masheb, PhD | VA Connecticut Healthcare System West Haven Campus, West Haven, CT | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA Connecticut Healthcare System West Haven Campus, West Haven, CT | West Haven | Connecticut | 06516-2770 | United States | ||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28271431 | Background | Masheb RM, Chan SH, Raffa SD, Ackermann R, Damschroder LJ, Estabrooks PA, Evans-Hudnall G, Evans NC, Histon T, Littman AJ, Moin T, Nelson KM, Pagoto S, Pronk NP, Tate DF, Goldstein MG. State of the art conference on weight management in VA: Policy and research recommendations for advancing behavioral interventions. J Gen Intern Med. 2017 Apr;32(Suppl 1):74-78. doi: 10.1007/s11606-016-3965-y. | |
| 32107681 |
Not provided
Not provided
Unable to share Veteran data
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | MOVE! | Weight management delivered as Treatment-as-Usual MOVE!: Participants randomized to the MOVE!(or TeleMOVE!) arm only. MOVE! is 16 weeks of 60-minute weekly groups that are led by a physical therapist, dietician, and/or clinical health psychologist. Clinicians utilize materials available online and encourage the use, but do not require or provide food diaries. TeleMOVE! is a 90-day program utilizing technology to provide home-based messaging focusing on health education and as needed clinician contact. *TeleMOVE! was added as an option since many in-person MOVE! programs were on pause due to the pandemic. |
| FG001 | MOVE!+CBT | Weight management delivered as Treatment-as-Usual plus use of a short duration, low-intensity CBT for recurrent binge eating. MOVE!+CBT: Participants randomized to the MOVE!+CBT arm will attend the 16 weeks of 60-minute weekly MOVE! or 90-days of the TeleMOVE! Treatment groups, along with up to 10 clinician-led individual sessions over a 3-month period. Participants will also be given a patient treatment manual to read at home, food diaries that will be expected to be completed on a daily basis, and gradually increase daily physical activity. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | MOVE! | Weight management delivered as Treatment-as-Usual MOVE!: Participants randomized to the MOVE!(or TeleMOVE!) arm only. MOVE! is 16 weeks of 60-minute weekly groups that are led by a physical therapist, dietician, and/or clinical health psychologist. Clinicians utilize materials available online and encourage the use, but do not require or provide food diaries. TeleMOVE! is a 90-day program utilizing technology to provide home-based messaging focusing on health education and as needed clinician contact. *TeleMOVE! was added as an option since many in-person MOVE! programs were on pause due to the pandemic. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Change in Eating Disorder Examination-Self-report Questionnaire (EDE-Q) | The EDE-Q is the self-report version of the more intensive EDE interview. Research has documented that the EDE-Q performs well as a measure of change in treatment trials and has adequate convergence with the interview format. The EDE-Q generates the same frequency data for eating behaviors (binge eating and overeating) in the past 28 days, and the same four subscales reflecting eating disorder pathology. Score on a scale 0-6; higher=worse | Number analyzed for each timepoint is reflected below. Note some participants were lost to follow-up at each timepoint. | Posted | Mean | Standard Error | score on a scale | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
AEs, SAEs, and UAPs were collected from the time of study entry until the end of study participation (a total of 15 months)
The overall risk for this study was minimal. The risks associated with assessments are only minor due to an inconvenience that may occur during their completion (frustrating/time-consuming). Risks associated with treatments may include no benefit or worsening of binge eating.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | MOVE! | Weight management delivered as Treatment-as-Usual MOVE!: Participants randomized to the MOVE!(or TeleMOVE!) arm only. MOVE! is 16 weeks of 60-minute weekly groups that are led by a physical therapist, dietician, and/or clinical health psychologist. Clinicians utilize materials available online and encourage the use, but do not require or provide food diaries. TeleMOVE! is a 90-day program utilizing technology to provide home-based messaging focusing on health education and as needed clinician contact. *TeleMOVE! was added as an option since many in-person MOVE! programs were on pause due to the pandemic. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Robin Masheb, PhD | VA Connecticut Healthcare System | 203-932-5711 | 3954 | Robin.Masheb@va.gov |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | May 16, 2024 | May 16, 2024 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D056912 | Binge-Eating Disorder |
| D002032 | Bulimia |
| ID | Term |
|---|---|
| D001068 | Feeding and Eating Disorders |
| D001523 | Mental Disorders |
| D006963 | Hyperphagia |
| D012817 | Signs and Symptoms, Digestive |
Not provided
Not provided
This is a randomized RCT in which one half of participants will be assigned to MOVE! (treatment-as-usual weight management) and the other half will be assigned to MOVE! plus the experimental condition (clinician-led Cognitive Behavioral Therapy).
Not provided
Not provided
Treating therapists will be blind to outcome data
|
| MOVE!+CBT | Behavioral | Participants randomized to the MOVE!+CBT arm will attend the 16 weeks of 60-minute weekly MOVE! or 90-days of the TeleMOVE! Treatment groups, along with up to 10 clinician-led individual sessions over a 3-month period. Participants will also be given a patient treatment manual to read at home, food diaries that will be expected to be completed on a daily basis, and gradually increase daily physical activity. |
|
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of Post Traumatic Stress Disorder (PTSD). Score on scale from 0-80; higher=worse |
| Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Weight and Eating Quality of Life (WE-QoL) | The WE-QoL is an 8-item self-report instrument for measurement of the impact weight and eating has on quality-of-life outcomes. Score on scale from 0-4; higher=worse | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Change in European Quality of Life (EuroQoL-5D) | The EuroQol-5D is a 5-item self-report instrument for measurement of quality of life outcomes that has specifically been used in weight loss trials with Veterans. The EuroQoL-5D also includes the Visual Analogue Scale (VAS) which is a measure of overall self-rated health status on a 100-point scale. Units on a scale (0-100); higher=better | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Night Eating Questionnaire (NEQ) | The NEQ is a 14-item self-report instrument for the measurement of Night Eating Syndrome (NES). A total score of greater than or equal to 25 indicates NES. Score on scale 0-52; higher=worse | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| CBT Session Attendance (Treatment Dose) | CBT session attendance will be determined by the number of clinician-led individual sessions attended throughout the treatment. | 3 month post-treatment |
The WCSS is a self-report instrument that assesses the use of specific weight loss behaviors. The measure has been shown to be valid, reliable and predictive of weight loss. Score on a scale 0-4; higher=better |
| Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Change in Godin Leisure Time Exercise Questionnaire (Godin) | The Godin is a 4-item, reliable self-report measure of physical activity that assesses the frequencies of strenuous, moderate and mild exercise and has been validated against accelerometers. Units on a scale 0-119; higher=better | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Treatment Satisfaction | Treatment satisfaction will be measured with a number of questions to measure participants' experience as a participant on a range from strongly disagree to strongly agree (e.g., "I increased my ability to manage my binge eating" and "How likely are you to recommend this treatment to other Veterans?"). Score on a scale 0-48; higher=better | 3 months post treatment |
| Change in Weight | All weights were taken by self-report at each timepoint. | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Loss of Control Overeating Scale (LOCES) | A self-administered scale used to assess features of loss of control over eating. Score on a scale 0-4; higher=worse | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0) | A self-administered scale used to assess the features of food addiction. Units on a scale 0-11; higher=worse | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
| VA Central Western Massachusetts Healthcare System, Leeds, MA |
| Leeds |
| Massachusetts |
| 01053-9764 |
| United States |
| Result |
| Masheb RM, Douglas ME, Kutz AM, Marsh AG, Driscoll M. Pain and emotional eating: further investigation of the Yale Emotional Overeating Questionnaire in weight loss seeking patients. J Behav Med. 2020 Jun;43(3):479-486. doi: 10.1007/s10865-020-00143-4. Epub 2020 Feb 27. |
| 36973571 | Result | Masheb RM, Snow JL, Fenn LM, Antoniadis NE, Raffa SD, Ruser CB, Buta E. Development and Psychometric Assessment of the Weight and Eating Quality of Life (WE-QOL) Scale in US Military Veterans. J Gen Intern Med. 2023 Jul;38(9):2076-2081. doi: 10.1007/s11606-023-08132-4. Epub 2023 Mar 27. |
| 37200510 | Result | Carr MM, Lou R, Macdonald-Gagnon G, Peltier MR, Funaro MC, Martino S, Masheb RM. Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review. Am J Drug Alcohol Abuse. 2023 Sep 3;49(5):551-565. doi: 10.1080/00952990.2023.2207720. Epub 2023 May 18. |
| 40485646 | Result | Masheb RM, Buta E, Snow JL, Munro LF, Lawless M, Abel EA, McWain NE, Marsh A, Cary A, Grilo CM, Raffa SD, Ruser CB. Randomized Controlled Trial of Weight Management Versus Weight Management With Concurrent Cognitive-Behavioral Therapy for Binge-Eating Disorder in US Veterans With High Weight. Int J Eat Disord. 2025 Sep;58(9):1777-1792. doi: 10.1002/eat.24476. Epub 2025 Jun 9. |
| BG001 | MOVE!+CBT | Weight management delivered as Treatment-as-Usual plus use of a short duration, low-intensity CBT for recurrent binge eating. MOVE!+CBT: Participants randomized to the MOVE!+CBT arm will attend the 16 weeks of 60-minute weekly MOVE! or 90-days of the TeleMOVE! Treatment groups, along with up to 10 clinician-led individual sessions over a 3-month period. Participants will also be given a patient treatment manual to read at home, food diaries that will be expected to be completed on a daily basis, and gradually increase daily physical activity. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex/Gender, Customized | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Number analyzed is reflective of the number of participants that completed the assessment. Numbers differ from total number of participants since one participant chose not to answer this question. | Count of Participants | Participants |
|
| Education | Count of Participants | Participants |
|
| Married | Count of Participants | Participants |
|
| Weight History | Mean | Standard Deviation | lbs |
|
| Mental Health | Count of Participants | Participants |
|
| OG001 | MOVE!+CBT | Weight management delivered as Treatment-as-Usual plus use of a short duration, low-intensity CBT for recurrent binge eating. MOVE!+CBT: Participants randomized to the MOVE!+CBT arm will attend the 16 weeks of 60-minute weekly MOVE! or 90-days of the TeleMOVE! Treatment groups, along with up to 10 clinician-led individual sessions over a 3-month period. Participants will also be given a patient treatment manual to read at home, food diaries that will be expected to be completed on a daily basis, and gradually increase daily physical activity. |
|
|
| Primary | Change in Binge Episodes From Eating Disorder Examination Interview | The EDE is a clinician administered interview that is considered to be the gold standard for diagnosing eating disorders and assessing binge frequency. Number of binges; higher=worse | Number analyzed for each timepoint is reflected below. Note some participants were lost to follow-up at each timepoint. | Posted | Mean | Standard Deviation | Number of binges | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Secondary | Change in Patient Health Questionnaire-9 (PHQ-9) | The PHQ-9 is a 9-item version, is a self-report measure for the symptoms of depression. Score on scale from 0-27; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Secondary | Change in PTSD Checklist (PCL-5) | The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of Post Traumatic Stress Disorder (PTSD). Score on scale from 0-80; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Secondary | Weight and Eating Quality of Life (WE-QoL) | The WE-QoL is an 8-item self-report instrument for measurement of the impact weight and eating has on quality-of-life outcomes. Score on scale from 0-4; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Secondary | Change in European Quality of Life (EuroQoL-5D) | The EuroQol-5D is a 5-item self-report instrument for measurement of quality of life outcomes that has specifically been used in weight loss trials with Veterans. The EuroQoL-5D also includes the Visual Analogue Scale (VAS) which is a measure of overall self-rated health status on a 100-point scale. Units on a scale (0-100); higher=better | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | units on a scale | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Secondary | Night Eating Questionnaire (NEQ) | The NEQ is a 14-item self-report instrument for the measurement of Night Eating Syndrome (NES). A total score of greater than or equal to 25 indicates NES. Score on scale 0-52; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Secondary | CBT Session Attendance (Treatment Dose) | CBT session attendance will be determined by the number of clinician-led individual sessions attended throughout the treatment. | Posted | Mean | Full Range | number of sessions | 3 month post-treatment |
|
|
|
| Other Pre-specified | Change in BMI | BMI will be calculated based upon self-reported height and weight. A BMI of 25.0-29.9 indicates overweight, and 30.0 above indicates obesity. Kg/m 2; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | kg/m^2 | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Other Pre-specified | Change in Weight Control Strategies Scale (WCSS) | The WCSS is a self-report instrument that assesses the use of specific weight loss behaviors. The measure has been shown to be valid, reliable and predictive of weight loss. Score on a scale 0-4; higher=better | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Other Pre-specified | Change in Godin Leisure Time Exercise Questionnaire (Godin) | The Godin is a 4-item, reliable self-report measure of physical activity that assesses the frequencies of strenuous, moderate and mild exercise and has been validated against accelerometers. Units on a scale 0-119; higher=better | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Other Pre-specified | Treatment Satisfaction | Treatment satisfaction will be measured with a number of questions to measure participants' experience as a participant on a range from strongly disagree to strongly agree (e.g., "I increased my ability to manage my binge eating" and "How likely are you to recommend this treatment to other Veterans?"). Score on a scale 0-48; higher=better | Posted | Mean | Standard Error | score on a scale | 3 months post treatment |
|
|
|
| Other Pre-specified | Change in Weight | All weights were taken by self-report at each timepoint. | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | lbs | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Other Pre-specified | Loss of Control Overeating Scale (LOCES) | A self-administered scale used to assess features of loss of control over eating. Score on a scale 0-4; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | score on a scale | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| Other Pre-specified | Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0) | A self-administered scale used to assess the features of food addiction. Units on a scale 0-11; higher=worse | Number analyzed is reflective of the number of participants that completed the assessment at each timepoint. Numbers differ from each timepoint due to those that were lost to follow-up. | Posted | Mean | Standard Error | units on a scale | Pre Treatment, 3 month post treatment, 9 month post treatment, 15 month post treatment |
|
|
|
| 1 |
| 56 |
| 0 |
| 56 |
| 0 |
| 56 |
| EG001 | MOVE!+CBT | Weight management delivered as Treatment-as-Usual plus use of a short duration, low-intensity CBT for recurrent binge eating. MOVE!+CBT: Participants randomized to the MOVE!+CBT arm will attend the 16 weeks of 60-minute weekly MOVE! or 90-days of the TeleMOVE! Treatment groups, along with up to 10 clinician-led individual sessions over a 3-month period. Participants will also be given a patient treatment manual to read at home, food diaries that will be expected to be completed on a daily basis, and gradually increase daily physical activity. | 0 | 53 | 0 | 53 | 0 | 53 |
Not provided
Not provided
Not provided
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| Other, not specified |
|
| Unknown or Not Reported |
|
| Completed College |
|
| Graduate School |
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 6 Months |
|
|
| 9 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|
| 3 Months |
|
|
| 9 Months |
|
|
| 15 Months |
|
|